U.S. flag

An official website of the United States government

NM_000525.4(KCNJ11):c.814C>T (p.Pro272Ser) AND Permanent neonatal diabetes mellitus

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Apr 22, 2025
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV005618434.1

Allele description [Variation Report for NM_000525.4(KCNJ11):c.814C>T (p.Pro272Ser)]

NM_000525.4(KCNJ11):c.814C>T (p.Pro272Ser)

Gene:
KCNJ11:potassium inwardly rectifying channel subfamily J member 11 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11p15.1
Genomic location:
Preferred name:
NM_000525.4(KCNJ11):c.814C>T (p.Pro272Ser)
HGVS:
  • NC_000011.10:g.17387278G>A
  • NG_012446.1:g.6382C>T
  • NG_122013.1:g.845G>A
  • NG_122014.1:g.191G>A
  • NM_000525.4:c.814C>TMANE SELECT
  • NM_001166290.2:c.553C>T
  • NM_001377296.1:c.553C>T
  • NM_001377297.1:c.553C>T
  • NP_000516.3:p.Pro272Ser
  • NP_001159762.1:p.Pro185Ser
  • NP_001364225.1:p.Pro185Ser
  • NP_001364226.1:p.Pro185Ser
  • NC_000011.9:g.17408825G>A
  • NM_000525.3:c.814C>T
Protein change:
P185S
Molecular consequence:
  • NM_000525.4:c.814C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001166290.2:c.553C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001377296.1:c.553C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001377297.1:c.553C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Permanent neonatal diabetes mellitus (PNDM)
Identifiers:
MONDO: MONDO:0100164; MedGen: C1833104; OMIM: PS606176

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV006294362Natera, Inc.
no assertion criteria provided
Uncertain significance
(Apr 22, 2025)
germlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Natera, Inc., SCV006294362.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jul 14, 2026

Modify your search Search (all fields optional) Clear all
Advanced Search